PositoAI/ US/ ProKidney Corp.

ProKidney Corp.

NasdaqCM: PROK · Healthcare

Positivity Index

#6,344 / 6,774

Global

#3,624 / 4,000

United States

Positivity Score

-16,538

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

ProKidney Corp. — Overview & Financial Snapshot

ProKidney Corp. (NasdaqCM: PROK) is a Healthcare company, ranked #6,344 of 6,774 companies globally and #3,624 of 4,000 in United States on PositoAI, with a Positivity Score of -16,538. Its market capitalisation is ₹5,388.12 Cr ($570.83M), P/E ratio is -2.6 and P/B ratio is -0.65. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

P/B Ratio -0.65

P/E Ratio -2.6

D/E Ratio 0.02

ROE -58.96%

Owes vs Owns ? 0.11× Low $0.11 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-51.92$-0.55

Forward EPS ₹-57.40$-0.61

Beta 1.80

Market Cap ₹5,388.12 Cr$570.83M

What these numbers mean →

What does ProKidney Corp. do?

What is ProKidney Corp.'s P/E and P/B ratio?

ProKidney Corp. has a P/E ratio of -2.6 and a P/B ratio of -0.65.

What is ProKidney Corp.'s debt-to-equity ratio?

ProKidney Corp. has a debt-to-equity ratio of 0.02.

How much does ProKidney Corp. owe compared with what it owns?

ProKidney Corp. owes $0.11 for every $1 it owns (balance sheet Jun 2026), which is low.

What is ProKidney Corp.'s Positivity rank?

ProKidney Corp. is ranked #6,344 of 6,774 companies globally and #3,624 of 4,000 in United States on PositoAI, with a Positivity Score of -16,538.

Does ProKidney Corp. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for ProKidney Corp..

Where can I read the latest news about ProKidney Corp.?

Recent headlines about ProKidney Corp. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does ProKidney Corp. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of ProKidney Corp.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.